Nordsjaellands Hospital
nordsjaellandshospital.dkLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
88
Active
24
Phase 3
3
Total enrollment
41,203
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Remifentanil | — | — | — | — | — | 1 | |
| Rocuronium | — | — | — | — | — | 1 | |
| Semaglutide Injectable Product | — | — | — | — | — | 1 | |
| Semaglutide 2.4mg | — | — | — | — | — | 1 | |
| Semaglutide placebo | — | — | — | — | — | 1 |
Next readouts
- 2027-04-01
- 2027-09
- 2028-06
Top conditions
- Postoperative Pain5
- Community-acquired Pneumonia4
- Pain3
- Cesarean Section3
- Abdomen, Acute3
- Colles' Fracture3
- COVID-192
- Fluid Overload2
Frequently asked questions about Nordsjaellands Hospital
- How many clinical trials does Nordsjaellands Hospital have on ClinicalTrials.gov?
- Nordsjaellands Hospital is listed as the lead sponsor on 88 clinical trials in ClinicalTrials.gov, 24 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Nordsjaellands Hospital's trials are in Phase 3?
- 3 of Nordsjaellands Hospital's trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does Nordsjaellands Hospital focus on?
- Nordsjaellands Hospital's most-studied conditions on ClinicalTrials.gov are Postoperative Pain, Community-acquired Pneumonia, Pain, Cesarean Section, Abdomen, Acute.
- When are Nordsjaellands Hospital's next clinical trial readouts?
- Nordsjaellands Hospital has 3 upcoming primary-completion readouts tracked here; the soonest is “Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation”, expected around 2027-04-01.